Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) FCF Margin (2023 - 2025)

Historic FCF Margin for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to 1473.38%.

  • Mangoceuticals' FCF Margin fell 5992300.0% to 1473.38% in Q3 2025 from the same period last year, while for Sep 2025 it was 1264.08%, marking a year-over-year decrease of 5446100.0%. This contributed to the annual value of 789.74% for FY2024, which is 1673300.0% up from last year.
  • Mangoceuticals' FCF Margin amounted to 1473.38% in Q3 2025, which was down 5992300.0% from 747.4% recorded in Q2 2025.
  • Mangoceuticals' FCF Margin's 5-year high stood at 462.94% during Q1 2024, with a 5-year trough of 2081.11% in Q1 2025.
  • In the last 3 years, Mangoceuticals' FCF Margin had a median value of 966.66% in 2024 and averaged 1102.82%.
  • In the last 5 years, Mangoceuticals' FCF Margin soared by 13358900bps in 2024 and then tumbled by -16181700bps in 2025.
  • Over the past 3 years, Mangoceuticals' FCF Margin (Quarter) stood at 694.73% in 2023, then tumbled by -54bps to 1073.26% in 2024, then crashed by -37bps to 1473.38% in 2025.
  • Its last three reported values are 1473.38% in Q3 2025, 747.4% for Q2 2025, and 2081.11% during Q1 2025.